HeartSciences receives Nasdaq delisting notice over $1.79M equity vs $2.5M minimum

HeartSciences Inc.

Received Nasdaq deficiency letter on March 19, 2025: stockholders' equity of $1.79M below $2.5M minimum.
Has 45 calendar days, until May 5, 2025, to submit a plan to regain compliance.
If plan accepted, Nasdaq may grant up to 180 days from March 19 to cure; no assurance.
Failure could lead to suspension/delisting, harming liquidity, market price, and financing ability.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.